Uncategorized
Biomarker testing needed in conjunctival melanoma management
CHICAGO — Searching for and treating biomarkers is an important part of conjunctival melanoma management, according to a presenter here.“Management of conjunctival melanoma is more than removing the lump on the surface of the eye,” Carol L. Shields, MD, said at Cornea Subspecialty Day preceding the American Academy of Ophthalmology meeting. “Now we look for molecular markers in all patients to identify high-risk melanoma, because we have medications for biomarkers.”